Features | Bellidifolin | Naringenin | Apigenin | Coptisine | Donepezil (positive control 1) | Galantamine (positive control 2) | Remarks (Best performers) |
---|---|---|---|---|---|---|---|
Molecular docking study | Good | Good | Good | Excellent | Good | Poor | Coptisine |
Druglikeness properties | Excellent | Excellent | Excellent | Excellent | Excellent | Excellent | All |
Absorption | Excellent | Excellent | Excellent | Poor | Good | Poor | Bellidifolin, naringenin, apigenin |
Distribution | Excellent | Excellent | Poor | Poor | Excellent | Good | Bellidifolin, naringenin |
Metabolism | Excellent | Poor | Good | Good | Good | Excellent | Bellidifolin |
Excretion | Good | Good | Good | Excellent | Excellent | Excellent | Coptisine |
Toxicity | Good | Excellent | Good | Excellent | Excellent | Excellent | Naringenin & apigenin |
PASS Prediction | Good | Good | Good | Good | Good | Good | All |
P450 SOM | Good | Excellent | Excellent | Poor | Good | Good | Naringenin, apigenin |
DFT calculations | Good | Good | Poor | Excellent | Good | Good | Coptisine |